This observation suggested that the combinatorial treatments could effectively counteract distinct apoptosis resistance mechanisms that hinder melanoma response to monotherapy based on TRAIL or target-specific inhibitors.9,35, 36, 37 This hypothesis was confirmed by investigation of several components of the extrinsic and intrinsic pathways of apoptosis. The gene discussed is TNFSF10; the disease is melanoma.